DYSREGULATED INTERLEUKIN-6 EXPRESSION PRODUCES A SYNDROME RESEMBLING CASTLEMANS DISEASE IN MICE

被引:309
|
作者
BRANDT, SJ
BODINE, DM
DUNBAR, CE
NIENHUIS, AW
机构
[1] Clinical Hematology Branch, Natl. Heart/Lung/Blood Inst., NIH, Bethesda
来源
JOURNAL OF CLINICAL INVESTIGATION | 1990年 / 86卷 / 02期
关键词
Gene transfer; Growth factor; Hypergammaglobulinemia; Lymphoproliferative disorder; Plasma cells;
D O I
10.1172/JCI114749
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Interleukin 6 (IL-6) is an important regulator of the acute phase response, T cell function, and terminal B cell differentiation. Excessive or inappropriate production of this cytokine may be involved in a variety of autoimmune and neoplastic disorders. To investigate the consequences of dysregulated synthesis of IL-6 in vivo, a high-titer recombinant retroviral vector produced in ψ-2 packaging cells was used to introduce the coding sequences of murine IL-6 into mouse hematopoietic cells. Congenitally anemic W/W(v) mice reconstituted with bone marrow cells transduced with the retroviral vector developed a syndrome characterized by anemia, transient granulocytosis, hypoalbuminemia, and polyclonal hypergammaglobulinemia, with marked splenomegaly and peripheral lymphadenopathy. Extensive plasma cell infiltration of lymph nodes, spleen, liver, and lung was noted. The similarity of these findings to those of multicentric Castleman's disease, taken together with the observation that lymph nodes from these patients elaborate large amounts of this cytokine, suggest that the inappropriate synthesis of IL-6 has a primary role in the pathogenesis of this systemic lymphoproliferative disorder.
引用
收藏
页码:592 / 599
页数:8
相关论文
共 50 条
  • [1] EXPRESSION OF INTERLEUKIN-6 IN CASTLEMANS DISEASE
    HSU, SM
    WALDRON, JA
    XIE, SS
    BARLOGIE, B
    HUMAN PATHOLOGY, 1993, 24 (08) : 833 - 839
  • [2] RETROVIRAL-MEDIATED TRANSFER OF INTERLEUKIN-6 INTO HEMATOPOIETIC-CELLS OF MICE RESULTS IN A SYNDROME RESEMBLING CASTLEMANS DISEASE
    BRANDT, SJ
    BODINE, DM
    DUNBAR, CE
    NIENHUIS, AW
    CURRENT TOPICS IN MICROBIOLOGY AND IMMUNOLOGY, 1990, 166 : 37 - 41
  • [3] CASTLEMANS DISEASE AND INTERLEUKIN-6
    YABUHARA, A
    KOMIYAMA, A
    LEUKEMIA & LYMPHOMA, 1990, 2 (06) : 369 - 380
  • [4] CASTLEMANS DISEASE IN POEMS SYNDROME WITH ELEVATED INTERLEUKIN-6
    MANDLER, RN
    KERRIGAN, DP
    SMART, J
    KUIS, W
    VILLIGER, P
    LOTZ, M
    CANCER, 1992, 69 (11) : 2697 - 2703
  • [5] INTERLEUKIN-6 GENE-EXPRESSION IN CASTLEMANS DISEASE
    LEGERRAVET, MB
    PEUCHMAUR, M
    DEVERGNE, O
    AUDOUIN, J
    RAPHAEL, M
    VANDAMME, J
    GALANAUD, P
    DIEBOLD, J
    EMILIE, D
    BLOOD, 1991, 78 (11) : 2923 - 2930
  • [6] EXPRESSION OF INTERLEUKIN-6 AND INTERLEUKIN-6 RECEPTOR IN HODGKINS-DISEASE
    JUCKER, M
    ABTS, H
    LI, W
    SCHINDLER, R
    MERZ, H
    GUNTHER, A
    VONKALLE, C
    SCHAADT, M
    DIAMANTSTEIN, T
    FELLER, AC
    KRUEGER, GRF
    DIEHL, V
    BLANKENSTEIN, T
    TESCH, H
    BLOOD, 1991, 77 (11) : 2413 - 2418
  • [7] PATHOGENIC SIGNIFICANCE OF INTERLEUKIN-6 (IL-6/BSF-2) IN CASTLEMANS DISEASE
    YOSHIZAKI, K
    MATSUDA, T
    NISHIMOTO, N
    KURITANI, T
    TAEHO, L
    AOZASA, K
    NAKAHATA, T
    KAWAI, H
    TAGOH, H
    KOMORI, T
    KISHIMOTO, S
    HIRANO, T
    KISHIMOTO, T
    BLOOD, 1989, 74 (04) : 1360 - 1367
  • [8] Chronic CNS expression of interleukin-6 produces changes in expression of STAT3 in transgenic mice.
    Kishikawa, H
    Castro, C
    Ling, C
    Potvin, D
    Lawrence, DA
    Turner, JN
    Campbell, IL
    Shain, W
    JOURNAL OF NEUROCHEMISTRY, 1998, 70 : S73 - S73
  • [9] HYPOGALACTOSYLATION OF IMMUNOGLOBULIN-G SUGAR CHAINS AND ELEVATED SERUM INTERLEUKIN-6 IN CASTLEMANS DISEASE
    NAKAO, H
    NISHIKAWA, A
    NISHIURA, T
    KANAYAMA, Y
    TARUI, S
    TANIGUCHI, N
    CLINICA CHIMICA ACTA, 1991, 197 (03) : 221 - 228
  • [10] REGULATION OF INTERLEUKIN-6 AND INTERLEUKIN-6 RECEPTOR EXPRESSION
    BAUER, J
    GEROK, W
    BIOLOGICAL CHEMISTRY HOPPE-SEYLER, 1990, 371 (03): : 186 - 186